Blue Horseshoe Stocks: CNDO Recap & Much More

Esperion Therapeutics, Inc. ESPR

ESPR was an unstoppable juggernaut for us this week. On Tuesday, we floated the idea of tracking the ESPR 04/17 $90 Calls, and those contracts have gone on a wild run since then.

As the stock pushed its way to new 52-week highs yesterday, finally topped those contracts out at 28.50, it marked an overall increase of 714% from the 3.50 low we observed on Tuesday; quite an impressive feat for a span of just three sessions.

Add in the multiplicity of opportunities in short-term weekly calls that we’ve witnessed (on the order of percentage gains in the thousands!) as the stock made this historical run, and we’ll have to mark ESPR down as one of our most successful alerts thus far in 2015.

Coronado BioSciences, Inc. CNDO

CNDO did quite well following our tag of it in yesterday morning’s extended watchlist, further solidifying the notion that biopharmas have been on a real hot streak this week.

We watched as CNDO ripped its way from a daily low of 3.62 to as high as 5.35, totaling an intraday run of 48% The move came on volume which smashed the 3-month average by a factor of more than 32X Congrats to any of our readers who lassoed this momentum-mover for some tidy gains yesterday!

Amicus Therapeutics, Inc. FOLD

FOLD also appear on yesterday’s watchlist before extending its own epic run with a modest yet notable increase of 13% on the day, trading a range from 11.63-13.20. Like the previously mentioned play, this stock has also been on a blue-sky breakout, setting new annual highs with every uptick.

Morning Gappers – Options Ideas

Nike, Inc. NKE shares surged as the company beat Wall St. estimates for profits on yesterday’s earnings call, and appears to be gapping up significantly in this morning’s premaket activity. We are going to be monitoring the $101-104 Weekly Calls for potential daytrading opportunities, and for a possible a swing trade into the weeks ahead, we’ll radar the 04/10 $105-110 Calls.

Prothena Corp plc PRTA is gapping up monstrously today to the tune of 40%, soaring on yesterday’s post-market revelation of positive Phase 1 results for its treatment for Parkinson’s disease. We will be placing $35 and 40 Calls on watch for daytrading potential, while tracking the 06/19 $45 Calls for a longer-term play.

Extended Watchlist:
VBLT, SPEX, VGGL, ICLD, RNN

Blue Horseshoe Stocks: ESPR Options, MVIS Recaps & More


Esperion Therapeutics, Inc. ESPR

ESPR found new highs once again yesterday for the second straight session after we initially tagged it for options trading potential on Tuesday.

In addition to monitoring Weekly In-the-money Calls, which yielded up the opportunity at gains ranging from 400-1400% on Tuesday, and continued their own runs yesterday, we also had specified a longer-term idea that continued to work extraordinarily well.

That idea, the 04/17 $90 Calls, traded from a low of 11.60 all the way up to 21.90 yesterday. It represented an excellent single-session intraday increase of 89%, and a whopping 525% jump over our observed low from Tuesday (3.50).

Big congratulations go out to any of our readers who reaped the benefits ESPR, which has easily emerged as our top target of the week! The stock is gapping up in the premarket this morning, so it appears as if we could see a further extension of those gains.

Microvision, Inc. MVIS

On Monday we tagged MVIS in a gap-up watchlist, and it has found its way into every one of our reports this week, setting new highs each day.

Yesterday the stock traded in a range from 3.42-4.23, a healthy intraday move of 24% From our observed low of 2.88 on Monday, that high marked a rise of 47% overall.

As you can see below, given the extremely over-bought look of the chart, now might be a good time to lock in any profits gained over the course of the week. This major move has been fueled by a PR out Monday in which the company announced orders totaling more than $14M it had received for components of its patented PicoP® display technology >> VIEW PR

Side Note:

Yesterday in advance of the FOMC Meeting, we cautioned readers to stay alert and watch for the effect that Janet Yellen’s commentary would have on the markets. To take advantage of this expected surge in either direction, we mentioned trading options calls on either the SPY, if the markets went up, or UVXY and/or VIX if they slid back.  Either way it played out, we said, we wanted “to stay in-the-money with our strike prices.”

As it turned out, the Fed announcement caused a sharp rise in the markets, and as a result the SPY Calls were the ones to play. We saw substantial gains on in-the-money Calls as the SPY spiked to $211.27.

For example, the SPY $209.50 Calls traded in a range from .80-2.00, for an intraday move totaling 150%  $210 Calls also spiked heavily from a low of .40 to as much as 1.59, a huge 297% jump.

Extended Watchlist:
FOLD, RAD, NQ, CNDO, SYN, SMLR

Blue Horseshoe Stocks: ESPR Highlights & Much More

Yesterday, on a day when the market as a whole was faltering, we’re proud to say we managed to bring our readers several opportunities to gain in both stocks and options:

Esperion Therapeutics, Inc. ESPR- Options Ideas

ESPR turned out to be a great call for us in yesterday’s morning report. The stock itself made an impressive session-long move from a low of 82.69 up to 100.50 (+22%), resulting in some monstrous spikes for the options ideas we highlighted.

We raised a flag of interest on in-the-money Weekly Calls, and were rewarded with mega-spikes across the board:

$80 Calls – Trading Range: 4.00-20.00  Max Gain: 400%
$85 Calls – Trading Range: 2.15-14.50  Max Gain: 574%
$90 Calls – Trading Range: .70-14.50  Max Gain: 1400%
$95 Calls – Trading Range: .64-7.25  Max Gain: 1032%

Even the play we designated as a longer-term selection, the 04/17 $90 Calls, were immediately and significantly impacted, trading in a range from 3.50-14.50. That move was good for intraday gains of up to 314%


As far as our other options calls were concerned, we met with success there as well:

American Airlines Group Inc. AAL – For AAL, we zeroed in on the 04/02 $55 Calls which ended up trading up from .79, to as high as 1.11, marking a 40% intraday gain. Any other contracts that got pushed into the money would have also provided excellent opportunities for successful day-trades.

Apple, Inc. AAPL – On AAPL, we mentioned that we’d be watching the 04/02 $129 Calls and those made a healthy run from 1.25-1.80, for a chance at profit in excess of 44% on the day.


Other Standouts From Tuesday

There was significant excitement over the success of our options calls yesterday, but we still don’t want these other notable gainers from our watchlist to get lost in the shuffle:

Propanc Health Group Corp. PPCH – Trading Range: .0211-.03 – Max Gain: 42%

Microvision, Inc. MVIS – Trading Range: 3.07-3.55 – Max Gain: 16%

NovaBay Pharma, Inc. NBY – Trading Range: .56-.65 – Max Gain: 16%

Black Diamond, Inc. BDE – Trading Range: 8.45-9.84 – Max Gain: 16%

Side Note:

We are going to be sitting on the sidelines watching like hawks until we hear from Janet Yellen as the big FOMC meeting kicks off today. What she ultimately has to say will likely sway the markets one way or the other; we will wait to see which direction they’re going to go.

If the bull market remains intact, we’ll be looking to go long on SPY Calls.  Should the direction be a downward one, we can entertain UVXY and/or VIX Calls. Remember: Whatever way it plays out, we’ll want to stay in-the-money with our strike prices.

Extended Watchlist:
VTSS, RTRX, ATNM, RXDX, AEZS, ZQK